Navigation Links
Yale researchers use uterine stem cells to treat diabetes
Date:9/14/2011

Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells.

The endometrium or uterine lining, is a source of adult stem cells. These cells generate uterine tissue each month as part of the menstrual cycle. Like other stem cells, however, they can divide to form other kinds of cells.

The Yale team's findings suggest that endometrial stem cells could be used to develop insulin-producing islet cells, which are found in the pancreas. These islet cells could then be used to advance the study of islet cell transplantation to treat people with diabetes.

Led by Yale Professor Hugh S. Taylor, M.D., the researchers bathed endometrial stem cells in cultures containing special nutrients and growth factors. Responding to these substances, the endometrial stem cells adopted the characteristics of beta cells in the pancreas that produce insulin. Over the course of a three-week incubation process, the endometrial stem cells took on the shape of beta cells and began to make proteins typically made by beta cells. Some of these cells also produced insulin.

After a meal, the body breaks food down into components like the sugar glucose, which then circulates in the blood. In response, beta cells release insulin, which allows the body's cells to take in the circulating glucose. In this study, Taylor and his team exposed the mature stem cells to glucose and found that, like typical beta cells, the cultured cells responded by producing insulin. The team then injected diabetic mice with the mature, insulin-making stem cells. The mice had few working beta cells and very high levels of blood glucose.

Mice that did not receive the stem cell therapy continued having high blood sugar levels, developed cataracts and were lethargic. In contrast, mice that received the cell therapy were active and did not develop cataracts, but the animals' blood sugar levels remained higher than normal.

Taylor said that the next step in the research will be to verify how long this treatment remains effective. "We will also investigate how changing the nutrient bath or increasing the dose of injected cells could make this treatment more effective," he said. "Endometrial stem cells might prove most useful for Type 1 diabetes, in which the immune system destroys the body's own insulin-producing cells. As a result, insulin is not available to control blood glucose levels."


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert  

Related medicine news :

1. Clemson researchers using interactive vision tool for driving studies
2. Researchers utilize neuroimaging to show how brain uses objects to recognize scenes
3. Researchers focus on secondary stroke prevention after study reveals room for improvement
4. Moffitt Cancer Center researchers use new tool to counter multiple myeloma drug resistance
5. Researchers find process that clears cholesterol and could reverse major cause of heart attack
6. Aerobic exercise may reduce the risk of dementia, Mayo Clinic researchers say
7. MU researchers use new video gaming technology to detect illness, prevent falls in older adults
8. Researchers develop new way to predict heart transplant survival
9. Researchers investigate new mechanism for predicting how diseases spread
10. Researchers successfully perform first injection of cultured red blood cells in human donor
11. Researchers share discoveries about aging-related changes in health and cognition
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Yale researchers use uterine stem cells to treat diabetes
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits delivery trailblazer, ... app and centralized benefits dashboard solving one of the top frustrations in employee ... For the first time, employees can access up-to-date information and account balances for ...
(Date:3/23/2017)... ... 23, 2017 , ... Hakim Unique Group (HUG) just closed ... Healthcom Group (CHG). , The HUG investment is a landmark move, expanding ... CHG is a growing, internationally recognized healthcare management, technology, and services organization. It ...
(Date:3/23/2017)... Scottsdale, AZ (PRWEB) , ... March 23, 2017 , ... ... helping people around the world to manage stress and anxiety. , “Buzzies change ... Serin, neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... of a new solution that enables organizations to easily reprint customer invoices, bills, ... Reprint Server’ automates all of the steps needed to retrieve and print the ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 /PRNewswire/ ... Teil von Piramal Enterprises Limited, gibt die ... Leiter bekannt. PPS bietet seinen globalen Pharmazeutikkunden ... Needleman wird eine wichtige Rolle für das ... spielen. Als kaufmännischer Leiter wird Herr Needleman ...
(Date:3/23/2017)... 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or ... pharmaceutical company, is pleased to announce that its ... from the U.S. Food and Drug Administration (FDA) ... for tetrabenazine tablets in the 12.5 mg and ... a generic equivalent of the branded product Xenazine ...
(Date:3/23/2017)... 2017 The global dermatology devices ... billion by 2025, according to a new report by Grand ... a faster rate due to rising concern amongst people regarding ... of esthetic procedures used for treating hair - and skin-related ... considered as the highest revenue generators for the market. ...
Breaking Medicine Technology: